Bachem Holding AG

BANB

Company Profile

  • Business description

    Bachem Holding AG is a biochemical company that provides services to the pharmaceutical and biotechnology industry. It focuses on specializing in the development and manufacture of peptides and oligonucleotides. The group markets its products under the Bachem and Clinalfa brands. It has two geographic segments Europe/Asia and USA. Its products and services are CMC Development, Commercial API, Research and Specialities, and Services and Capabilities.

  • Contact

    Hauptstrasse 144
    Bubendorf4416
    CHE

    T: +41 585952021

    E: [email protected]

    https://www.bachem.com

  • Sector

    Basic Materials

    Stock type

    Cyclical

  • Industry

    Chemicals

    Fiscal Year End

    31 December 2025

    Employees

    2,292

Stocks News & Analysis

stocks

Eagers international foray

Our view on CanadaOne acquisition.
stocks

Tesla: Shares down despite record deliveries

We think the positive third-quarter numbers will be largely offset by a weak fourth quarter.
stocks

ASX listed share dominates their industry

Shares are currently fairly valued with a Wide Moat rating.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,288.1053.600.58%
CAC 408,081.5424.910.31%
DAX 4024,378.8043.76-0.18%
Dow JONES (US)46,803.51283.790.61%
FTSE 1009,491.2563.520.67%
HKSE27,140.92146.20-0.54%
NASDAQ22,785.1758.88-0.26%
Nikkei 22545,769.50832.771.85%
NZX 50 Index13,514.0962.330.46%
S&P 5006,720.344.990.07%
S&P/ASX 2008,987.4050.800.57%
SSE Composite Index3,882.7820.250.52%

Market Movers